Scientific Opinion on the substantiation of health claims related to alpha linolenic acid (ALA) and brain and neurological development (ID 491), “molecule precursors regulating cell functions” (ID 492, 4671), maintenance of normal cardiac function (ID 509, 579), “nutrient tasks and interactions” (ID 576), maintenance of normal blood pressure (ID 575), and enhancement of mood (ID 578, 601, 3182) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Published:
Adopted:
Meta data
Keywords
Alpha-linolenic acid (ALA), brain development, cardiac function, blood pressure, mood, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-1278
EFSA-Q-2008-1279
EFSA-Q-2008-1296
EFSA-Q-2008-1362
EFSA-Q-2008-1363
EFSA-Q-2008-1365
EFSA-Q-2008-1366
EFSA-Q-2008-1388
EFSA-Q2008-3914
EFSA-Q-2010-00624
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Contact
Abstract
No abstract available
© European Food Safety Authority, 2011